Taylor Carolyn W, Wang Zhe, Macaulay Elizabeth, Jagsi Reshma, Duane Frances, Darby Sarah C
Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Int J Radiat Oncol Biol Phys. 2015 Nov 15;93(4):845-53. doi: 10.1016/j.ijrobp.2015.07.2292. Epub 2015 Aug 3.
Breast cancer radiation therapy cures many women, but where the heart is exposed, it can cause heart disease. We report a systematic review of heart doses from breast cancer radiation therapy that were published during 2003 to 2013.
Eligible studies were those reporting whole-heart dose (ie, dose averaged over the whole heart). Analyses considered the arithmetic mean of the whole-heart doses for the CT plans for each regimen in each study. We termed this "mean heart dose."
In left-sided breast cancer, mean heart dose averaged over all 398 regimens reported in 149 studies from 28 countries was 5.4 Gy (range, <0.1-28.6 Gy). In regimens that did not include the internal mammary chain (IMC), average mean heart dose was 4.2 Gy and varied with the target tissues irradiated. The lowest average mean heart doses were from tangential radiation therapy with either breathing control (1.3 Gy; range, 0.4-2.5 Gy) or treatment in the lateral decubitus position (1.2 Gy; range, 0.8-1.7 Gy), or from proton radiation therapy (0.5 Gy; range, 0.1-0.8 Gy). For intensity modulated radiation therapy mean heart dose was 5.6 Gy (range, <0.1-23.0 Gy). Where the IMC was irradiated, average mean heart dose was around 8 Gy and varied little according to which other targets were irradiated. Proton radiation therapy delivered the lowest average mean heart dose (2.6 Gy, range, 1.0-6.0 Gy), and tangential radiation therapy with a separate IMC field the highest (9.2 Gy, range, 1.9-21.0 Gy). In right-sided breast cancer, the average mean heart dose was 3.3 Gy based on 45 regimens in 23 studies.
Recent estimates of typical heart doses from left breast cancer radiation therapy vary widely between studies, even for apparently similar regimens. Maneuvers to reduce heart dose in left tangential radiation therapy were successful. Proton radiation therapy delivered the lowest doses. Inclusion of the IMC doubled typical heart dose.
乳腺癌放射治疗治愈了许多女性患者,但当心脏受到照射时,可能会引发心脏病。我们对2003年至2013年期间发表的关于乳腺癌放射治疗心脏剂量的研究进行了系统综述。
符合条件的研究是那些报告全心剂量(即整个心脏的平均剂量)的研究。分析考虑了每项研究中每种治疗方案的CT计划全心剂量的算术平均值。我们将其称为“平均心脏剂量”。
在左侧乳腺癌中,来自28个国家的149项研究报告的398种治疗方案的平均心脏剂量平均为5.4 Gy(范围,<0.1 - 28.6 Gy)。在不包括内乳链(IMC)的治疗方案中,平均平均心脏剂量为4.2 Gy,并随照射的靶组织而变化。平均心脏剂量最低的是采用呼吸控制的切线放射治疗(1.3 Gy;范围,0.4 - 2.5 Gy)或侧卧位治疗(1.2 Gy;范围,0.8 - 1.7 Gy),或质子放射治疗(0.5 Gy;范围,0.1 - 0.8 Gy)。调强放射治疗的平均心脏剂量为5.6 Gy(范围,<0.1 - 23.0 Gy)。当照射IMC时,平均平均心脏剂量约为8 Gy,并且根据照射的其他靶组织不同变化不大。质子放射治疗的平均平均心脏剂量最低(2.6 Gy,范围,1.0 - 6.0 Gy),而采用单独IMC野的切线放射治疗最高(9.2 Gy,范围,1.9 - 21.0 Gy)。在右侧乳腺癌中,基于23项研究中的45种治疗方案,平均平均心脏剂量为3.3 Gy。
即使对于看似相似的治疗方案,不同研究对左侧乳腺癌放射治疗典型心脏剂量的近期估计差异也很大。在左侧切线放射治疗中降低心脏剂量的措施是成功的。质子放射治疗的剂量最低。纳入IMC会使典型心脏剂量增加一倍。